Eqis Capital Management, Inc. Moderna, Inc. Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

A detailed history of Eqis Capital Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 5,370 shares of MRNA stock, worth $216,249. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,370

Previous 6,602 18.66%

Holding current value

$216,249

Previous $783,000 54.28%

% of portfolio

0.03%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $78,404 - $154,172	-1,232 Reduced 18.66%	5,370 $358,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $95,542 - $157,279	-944 Reduced 12.51%	6,602 $783,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $91,004 - $123,059	-1,066 Reduced 12.38%	7,546 $804,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $24,398 - $36,654	351 Added 4.25%	8,612 $856,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $91,011 - $119,519	-944 Reduced 10.26%	8,261 $853,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $84,846 - $114,939	-716 Reduced 7.22%	9,205 $1.12 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $8,546 - $12,412	-63 Reduced 0.63%	9,921 $1.52 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $69,607 - $123,503	-588 Reduced 5.56%	9,984 $1.79 Million
Q3 2022 Oct 24, 2022	SELL	$118.07 - $194.18 $14,640 - $24,078	-124 Reduced 1.16%	10,572 $1.25 Million
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $298,447 - $449,951	-2,548 Reduced 19.24%	10,696 $1.53 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $407,074 - $756,625	-3,219 Reduced 19.55%	13,244 $2.28 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $106,361 - $173,568	471 Added 2.95%	16,463 $4.18 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $2.57 Million - $5.61 Million	-11,589 Reduced 42.02%	15,992 $6.16 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $537,307 - $971,877	-4,136 Reduced 13.04%	27,581 $6.48 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $3.46 Million - $5.9 Million	31,717 New	31,717 $4.15 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Moderna, Inc. Transaction History